AIM: To evaluate the prognostic significance of p27(kip1) in colorectal cancer patients. METHODS: Cytoplasmic and nuclear p27(kip1) expression was evaluated in 418 colorectal cancers using tissue microarrays. Data were associated with known patient and tumor variables and long-term patient outcomes, providing further insight into the mechanisms by which p27(kip1) may influence tumor development. RESULTS: Nuclear and cytoplasmic p27(kip1) expressions were detected in 59% and 19% of tumors respectively. Cytoplasmic p27(kip1) was almost invariably associated with positive nuclear p27(kip1) expression. Neither case correlated with known clinical or pathological variables, including tumor stage, grade or extramural vascular invasion. Furthermore, nuclear p27(kip1) expression had no impact on survival. However, we identified a significant correlation between expression of cytoplasmic p27(kip1) and longer disease-specific survival times. On multivariate analysis, TNM stage and extramural vascular invasion were highly significant independent prognostic factors, with positive cytoplasmic p27 expression showing a trend towards improved patient survival (P = 0.059). CONCLUSION: These findings support the recent evidence that cytoplasmic p27(kip1) has a distinct and important biological role that can influence tumor outcome.
AIM: To evaluate the prognostic significance of p27(kip1) in colorectal cancerpatients. METHODS: Cytoplasmic and nuclear p27(kip1) expression was evaluated in 418 colorectal cancers using tissue microarrays. Data were associated with known patient and tumor variables and long-term patient outcomes, providing further insight into the mechanisms by which p27(kip1) may influence tumor development. RESULTS: Nuclear and cytoplasmic p27(kip1) expressions were detected in 59% and 19% of tumors respectively. Cytoplasmic p27(kip1) was almost invariably associated with positive nuclear p27(kip1) expression. Neither case correlated with known clinical or pathological variables, including tumor stage, grade or extramural vascular invasion. Furthermore, nuclear p27(kip1) expression had no impact on survival. However, we identified a significant correlation between expression of cytoplasmic p27(kip1) and longer disease-specific survival times. On multivariate analysis, TNM stage and extramural vascular invasion were highly significant independent prognostic factors, with positive cytoplasmic p27 expression showing a trend towards improved patient survival (P = 0.059). CONCLUSION: These findings support the recent evidence that cytoplasmic p27(kip1) has a distinct and important biological role that can influence tumor outcome.
Authors: Nicholas F S Watson; Lindy G Durrant; Zahra Madjd; Ian O Ellis; John H Scholefield; Ian Spendlove Journal: Cancer Immunol Immunother Date: 2005-09-03 Impact factor: 6.968
Authors: Axel Hoos; Aviram Nissan; Alexander Stojadinovic; Jinru Shia; Cyrus V Hedvat; Denis H Y Leung; Philip B Paty; David Klimstra; Carlos Cordon-Cardo; W Douglas Wong Journal: Clin Cancer Res Date: 2002-12 Impact factor: 12.531
Authors: A Sgambato; C Ratto; B Faraglia; M Merico; R Ardito; G Schinzari; G Romano; A R Cittadini Journal: Mol Carcinog Date: 1999-11 Impact factor: 4.784
Authors: K Günther; A Jung; U Völker; M Meyer; T Brabletz; K E Matzel; M A Reymond; T Kirchner; W Hohenberger Journal: J Surg Res Date: 2000-07 Impact factor: 2.192
Authors: A C Leong; A M Hanby; H W Potts; D S Tan; D Skilton; K Ryder; W H Harris; R D Liebmann; D M Barnes; C E Gillett Journal: Int J Cancer Date: 2000-01-20 Impact factor: 7.396
Authors: Roger W McGilvray; Robert A Eagle; Nicholas F S Watson; Ahmad Al-Attar; Graham Ball; Insiya Jafferji; John Trowsdale; Lindy G Durrant Journal: Clin Cancer Res Date: 2009-10-27 Impact factor: 12.531
Authors: Shuji Ogino; Kaori Shima; Katsuhiko Nosho; Natsumi Irahara; Yoshifumi Baba; Brian M Wolpin; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-06 Impact factor: 4.254